Showing results (2071-2080 of 4,138) with videos related to
Sort By:
Pageof 414
Human Gene Therapy|September 6, 2001
In vivo persistence of retrovirally transduced murine long-term repopulating cells is not limited by expression of foreign gene products in the fully or minimally myeloablated settingE Kang, N Giri, T Wu, et al.Human Gene Therapy|May 29, 2002
Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry diseaseRobin J Ziegler, Chester Li, Maribeth Cherry, et al.Human Gene Therapy|May 29, 2002
Effective retrovirus-mediated gene transfer in normal and mutant human melanocytesMaria Vittoria Schiaffino, Elena Dellambra, Katia Cortese, et al.Human Gene Therapy|May 29, 2002
A preclinical model for the analysis of genetically modified human skin in vivoMarcela Del Rio, Fernando Larcher, Fernando Serrano, et al.Human Gene Therapy|May 29, 2002
Clinical-scale selection of anti-CD3/CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptorPaul J Orchard, Bruce R Blazar, Scott Burger, et al.Human Gene Therapy|June 18, 2002
Rapid screening for high-titer retroviral packaging cell lines using an in situ fluorescence assayBronwyn J Green, John E J RaskoHuman Gene Therapy|June 18, 2002
Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNAMario R Mautino, Richard A MorganHuman Gene Therapy|June 18, 2002
Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapyGyula Acsadi, Roumen A Anguelov, Huibin Yang, et al.Human Gene Therapy|June 18, 2002
Efficient oncoretroviral transduction of extended long-term culture-initiating cells and NOD/SCID repopulating cells: enhanced reconstitution with gene-marked cells through an ex vivo expansion approachHelga Björgvinsdóttir, David Bryder, Ewa Sitnicka, et al.Human Gene Therapy|July 23, 2002
A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparationsFlorian Kreppel, Volker Biermann, Stefan Kochanek, et al.Pageof 414